US Nicotinamide Prices Extend Decline in July as Cautious Buying Weighs on Market

The U.S. Nicotinamide market remained under mild bearish pressure during July 2026, with prices declining moderately following a 1.91% drop recorded in June. The softer pricing environment was primarily attributed to comfortable domestic inventories, stable import availability, and restrained procurement activity from downstream industries. Despite healthy consumption across pharmaceutical, nutraceutical, and personal care applications, buyers continued to adopt a cautious purchasing strategy, limiting spot market transactions and preventing any meaningful price recovery.

Supply fundamentals remained largely balanced for Nicotinamide throughout the month. Regular import arrivals from Asian manufacturing hubs ensured sufficient product availability, while improved shipping reliability across major trans-Pacific trade routes supported consistent supply into the U.S. market. Freight rates remained relatively stable compared with the volatility observed earlier this year, reducing logistical cost pressures for importers. At the same time, production costs for Nicotinamide showed limited fluctuations as upstream raw material markets remained broadly steady, allowing suppliers to maintain competitive offers without significant upward price revisions.

Demand conditions, meanwhile, reflected mixed market sentiment for Nicotinamide. Pharmaceutical manufacturers continued to procure material based on production requirements, while demand from dietary supplement and cosmetic manufacturers remained stable but lacked the momentum needed to tighten supply. Several downstream buyers preferred utilizing existing inventories of Nicotinamide before placing fresh orders, anticipating further pricing flexibility from suppliers. This hand-to-mouth procurement pattern reduced overall trading activity and encouraged sellers to offer competitive pricing in order to stimulate sales volumes, resulting in the moderate decline observed during the month.

Market participants also noted that adequate stock levels across the distribution network reduced any urgency for Nicotinamide replenishment. Suppliers focused on maintaining inventory turnover rather than pursuing aggressive price increases, as competition among importers remained relatively strong. Consequently, the Nicotinamide market experienced limited volatility despite steady end-use consumption, with pricing largely influenced by cautious buying behavior rather than any significant disruption in supply or production.

Looking ahead, market sentiment for Nicotinamide is expected to improve in August. Industry participants anticipate a gradual increase in procurement activity as buyers begin replenishing inventories after delaying purchases during the previous two months. Seasonal demand from nutraceutical and pharmaceutical manufacturers is also expected to strengthen, supporting higher transaction volumes. In addition, any improvement in export quotations from key Asian suppliers or an increase in international freight costs could raise import parity values in the U.S. market. These factors, combined with potentially tighter inventories resulting from improved purchasing activity, are anticipated to support a moderate rebound in Nicotinamide prices during August, reversing the recent downward trend while keeping overall market fundamentals balanced.